The Role of Radiation Therapy In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma is organized by American Society for Radiation Oncology (ASTRO) and will be held from Jan 31, 2018 - Jan 30, 2020.

The target audience for this medical event is radiation oncologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credit.

Provides practitioners with clear guidelines for managing relapsed lymphomas and clear information about new targeted agents now in regular use.

Learning Objectives :
Upon completion of this activity, participants should be able to:
• Define the appropriate use of radiation in the management of refractory lymphoma.

Additional details will be posted as soon as they are available.

Intended Audience

Radiation Oncology, Haematology

Activity Payment Details

Activity Fee : USD $30.00

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Society for Radiation Oncology (ASTRO)

View Organizer Details